Histone deacetylase inhibitors specifically kill nonproliferating tumour cells (Q40538874)

21 September 2017

title

Histone deacetylase inhibitors specifically kill nonproliferating tumour cells (English)

1 reference

21 September 2017

Andrew Burgess

1

0 references

Nicholas A Saunders

object named as

Nicholas Saunders

5

0 references

Ricky W Johnstone

object named as

Ricky Johnstone

6

0 references

author name string

Astrid Ruefli

2

1 reference

21 September 2017

Heather Beamish

3

1 reference

21 September 2017

Robyn Warrener

4

1 reference

21 September 2017

Brian Gabrielli

7

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

23

1 reference

21 September 2017

issue

40

1 reference

21 September 2017

page(s)

6693-6701

1 reference

p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

BH3 domains: intracellular death-ligands critical for initiating apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

Identifying molecular targets mediating the anticancer activity of histone deacetylase inhibitors: a work in progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

Histone deacetylase inhibitors as new cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

Molecular sequelae of histone deacetylase inhibition in human malignant B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

inferred from DOI database lookup

7 January 2021

based on heuristic

Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207893

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1207893

1 reference

Dimensions Publication ID

21 September 2017

1014820759

0 references

1 reference